Abstract
Tumor infiltrating leukocytes comprise a significant population of cells in the tumor microenvironment. Pathologic evaluation of tumors by methods of light microscopy and immunohistochemistry allow identification of all types of leukocytes, including the cells of myeloid, monocytoid and lymphoid origin. The density of these cells, their spatial distribution in tumor islets and stroma, their level of maturation and functional status vary considerably in the tumors of different nature, grade and stage. By the analysis of clinical data it has been shown that specific types of tumor infiltrating leukocytes have a major impact on the clinical course and the outcome of malignant diseases. This chapter describes an approach used by pathologists to gain insight into morphologic and functional properties of tumor infiltrating leukocytes, as well as their prognostic significance.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Acikalin MF, Oner U, Topcu I, Yasar B, Kiper H, Colak E (2005) Tumour angiogenesis and mast cell density in the prognostic assessment of colorectal carcinomas. Dig Liver Dis 37(3):162–169
Adelstein EH, Davis WE, Oxenhandler RW, Templer JW, Barrett BA (1978) Lymphocyte-tumor cell interaction in patients with head and neck cancer. Laryngoscope 88(4):575–581
Allen C, Hogg N (1987) Elevation of infiltrating mononuclear phagocytes in human colorectal tumors. J Natl Cancer Inst 78(3):465–470
Almholt K, Johnsen M (2003) Stromal cell involvement in cancer. Recent results in cancer research Fortschritte der Krebsforschung 162:31–42
Al-Shibli KI, Donnem T, Al-Saad S, Persson M, Bremnes RM, Busund LT (2008) Prognostic effect of epithelial and stromal lymphocyte infiltration in non-small cell lung cancer. Clin Cancer Res 14(16):5220–5227
Al-Shibli K, Al-Saad S, Donnem T, Persson M, Bremnes RM, Busund LT (2009) The prognostic value of intraepithelial and stromal innate immune system cells in non-small cell lung carcinoma. Histopathology 55(3):301–312
Al-Shibli K, Al-Saad S, Andersen S, Donnem T, Bremnes RM, Busund LT (2010) The prognostic value of intraepithelial and stromal CD3-, CD117- and CD138-positive cells in non-small cell lung carcinoma. Apmis 118(5):371–382
Ambe K, Mori M, Enjoji M (1989) S-100 protein-positive dendritic cells in colorectal adenocarcinomas. Distribution and relation to the clinical prognosis. Cancer 63(3):496–503
Amini RM, Aaltonen K, Nevanlinna H et al (2007) Mast cells and eosinophils in invasive breast carcinoma. BMC cancer 7:165
Ancuta E, Ancuta C, Zugun-Eloae F, Iordache C, Chirieac R, Carasevici E (2009) Predictive value of cellular immune response in cervical cancer. Rom J Morphol Embryol = Revue roumaine de morphologie et embryologie 50(4):651–655
Aoki M, Pawankar R, Niimi Y, Kawana S (2003) Mast cells in basal cell carcinoma express VEGF, IL-8 and RANTES. Int Arch Allergy Immunol 130(3):216–223
Ardi VC, Kupriyanova TA, Deryugina EI, Quigley JP (2007) Human neutrophils uniquely release TIMP-free MMP-9 to provide a potent catalytic stimulator of angiogenesis. Proc Natl Acad Sci USA 104(51):20262–20267
Ardi VC, Van den Steen PE, Opdenakker G, Schweighofer B, Deryugina EI, Quigley JP (2009) Neutrophil MMP-9 proenzyme, unencumbered by TIMP-1, undergoes efficient activation in vivo and catalytically induces angiogenesis via a basic fibroblast growth factor (FGF-2)/FGFR-2 pathway. J Biol Chem 284(38):25854–25866
Aso T, Ogawa Y, Naoe M, Fukagai T, Yoshida H, Kushima M (2004) Immunohistochemical analysis of CD83, CD8 and CD4 positive cells in renal cell carcinoma. Nihon Hinyokika Gakkai zasshi 95(4):645–650
Asselin-Paturel C, Boonstra A, Dalod M et al (2001) Mouse type I IFN-producing cells are immature APCs with plasmacytoid morphology. Nat Immunol 2(12):1144–1150
Baay M, Brouwer A, Pauwels P, Peeters M, Lardon F (2011) Tumor cells and tumor-associated macrophages: secreted proteins as potential targets for therapy. Clin Dev Immunol 2011:565187
Baj-Krzyworzeka M, Szatanek R, Weglarczyk K, Baran J, Zembala M (2007) Tumour-derived microvesicles modulate biological activity of human monocytes. Immunol Lett 113(2):76–82
Balkwill F, Mantovani A (2001) Inflammation and cancer: back to Virchow? Lancet 357(9255):539–545
Bates GJ, Fox SB, Han C et al (2006) Quantification of regulatory T cells enables the identification of high-risk breast cancer patients and those at risk of late relapse. J Clin Oncol 24(34):5373–5380
Bechara C, Chai H, Lin PH, Yao Q, Chen C (2007) Growth related oncogene-alpha (GRO-alpha): roles in atherosclerosis, angiogenesis and other inflammatory conditions. Med Sci Monit 13(6):RA87–RA90
Bell D, Chomarat P, Broyles D et al (1999) In breast carcinoma tissue, immature dendritic cells reside within the tumor, whereas mature dendritic cells are located in peritumoral areas. J Exp Med 190(10):1417–1426
Bellocq A, Antoine M, Flahault A et al (1998) Neutrophil alveolitis in bronchioloalveolar carcinoma: induction by tumor-derived interleukin-8 and relation to clinical outcome. Am J Pathol 152(1):83–92
Belotti D, Paganoni P, Manenti L et al (2003) Matrix metalloproteinases (MMP9 and MMP2) induce the release of vascular endothelial growth factor (VEGF) by ovarian carcinoma cells: implications for ascites formation. Cancer Res 63(17):5224–5229
Benitez-Bribiesca L, Wong A, Utrera D, Castellanos E (2001) The role of mast cell tryptase in neoangiogenesis of premalignant and malignant lesions of the uterine cervix. J Histochem Cytochem 49(8):1061–1062
Bergers G, Brekken R, McMahon G et al (2000) Matrix metalloproteinase-9 triggers the angiogenic switch during carcinogenesis. Nat Cell Biol 2(10):737–744
Bethwaite PB, Holloway LJ, Yeong ML, Thornton A (1993) Effect of tumour associated tissue eosinophilia on survival of women with stage IB carcinoma of the uterine cervix. J Clin Pathol 46(11):1016–1020
Bigotti G, Coli A, Castagnola D (1991) Distribution of Langerhans cells and HLA class II molecules in prostatic carcinomas of different histopathological grade. Prostate 19(1):73–87
Bingle L, Brown NJ, Lewis CE (2002) The role of tumour-associated macrophages in tumour progression: implications for new anticancer therapies. J Pathol 196(3):254–265
Bostrom SG, Hart WR (1981) Carcinomas of the cervix with intense stromal eosinophilia. Cancer 47(12):2887–2893
Bratt J, Palmblad J (1997) Cytokine-induced neutrophil-mediated injury of human endothelial cells. J Immunol 159(2):912–918
Cabanillas-Saez A, Schalper JA, Nicovani SM, Rudolph MI (2002) Characterization of mast cells according to their content of tryptase and chymase in normal and neoplastic human uterine cervix. Int J Gynecol Cancer 12(1):92–98
Cai XY, Gao Q, Qiu SJ et al (2006) Dendritic cell infiltration and prognosis of human hepatocellular carcinoma. J Cancer Res Clin Oncol 132(5):293–301
Cai D, Cao J, Li Z et al (2009) Up-regulation of bone marrow stromal protein 2 (BST2) in breast cancer with bone metastasis. BMC cancer 9:102
Cao W, Bover L (2010) Signaling and ligand interaction of ILT7: receptor-mediated regulatory mechanisms for plasmacytoid dendritic cells. Immunol Rev 234(1):163–176
Carrega P, Morandi B, Costa R et al (2008) Natural killer cells infiltrating human nonsmall-cell lung cancer are enriched in CD56 bright CD16(-) cells and display an impaired capability to kill tumor cells. Cancer 112(4):863–875
Caruso RA, Bellocco R, Pagano M, Bertoli G, Rigoli L, Inferrera C (2002) Prognostic value of intratumoral neutrophils in advanced gastric carcinoma in a high-risk area in northern Italy. Mod Pathol 15(8):831–837
Caux C, Ait-Yahia S, Chemin K et al (2000) Dendritic cell biology and regulation of dendritic cell trafficking by chemokines. Springer Semin Immunopathol 22(4):345–369
Chambers SK, Kacinski BM, Ivins CM, Carcangiu ML (1997) Overexpression of epithelial macrophage colony-stimulating factor (CSF-1) and CSF-1 receptor: a poor prognostic factor in epithelial ovarian cancer, contrasted with a protective effect of stromal CSF-1. Clin Cancer Res 3(6):999–1007
Chaperot L, Blum A, Manches O et al (2006) Virus or TLR agonists induce TRAIL-mediated cytotoxic activity of plasmacytoid dendritic cells. J Immunol 176(1):248–255
Charles J, Di Domizio J, Salameire D et al (2010) Characterization of circulating dendritic cells in melanoma: role of CCR6 in plasmacytoid dendritic cell recruitment to the tumor. J Invest Dermatol 130(6):1646–1656
Chen WK, Chen FJ, Zeng ZY et al (2005) [Expression and clinical significance of CD1a+ dendritic cells in glottic squamous cell carcinoma]. Ai zheng = Aizheng = Chin J Cancer 24(9):1124–1126
Chiba T, Ohtani H, Mizoi T et al (2004) Intraepithelial CD8+ T-cell-count becomes a prognostic factor after a longer follow-up period in human colorectal carcinoma: possible association with suppression of micrometastasis. Br J Cancer 91(9):1711–1717
Chin Y, Janseens J, Vandepitte J, Vandenbrande J, Opdebeek L, Raus J (1992) Phenotypic analysis of tumor-infiltrating lymphocytes from human breast cancer. Anticancer Res 12(5):1463–1466
Ch’ng S, Wallis RA, Yuan L, Davis PF, Tan ST (2006) Mast cells and cutaneous malignancies. Mod Pathol 19(1):149–159
Cho Y, Miyamoto M, Kato K et al (2003) CD4+ and CD8+ T cells cooperate to improve prognosis of patients with esophageal squamous cell carcinoma. Cancer Res 63(7):1555–1559
Coca S, Perez-Piqueras J, Martinez D et al (1997) The prognostic significance of intratumoral natural killer cells in patients with colorectal carcinoma. Cancer 79(12):2320–2328
Coffelt SB, Lewis CE, Naldini L, Brown JM, Ferrara N, De Palma M (2010) Elusive identities and overlapping phenotypes of proangiogenic myeloid cells in tumors. Am J Pathol 176(4):1564–1576
Colasante A, Poletti V, Rosini S, Ferracini R, Musiani P (1993) Langerhans cells in Langerhans cell histiocytosis and peripheral adenocarcinomas of the lung. Am Rev Respir Dis 148(3):752–759
Colasante A, Castrilli G, Aiello FB, Brunetti M, Musiani P (1995) Role of cytokines in distribution and differentiation of dendritic cell/Langerhans’ cell lineage in human primary carcinomas of the lung. Hum Pathol 26(8):866–872
Coli A, Bigotti G, Cione T (1990) Langerhans cell and HLA class II molecules distribution in lung carcinoma. J Nucl Med Allied Sci 34(4 Suppl):185–189
Condeelis J, Pollard JW (2006) Macrophages: obligate partners for tumor cell migration, invasion, and metastasis. Cell 124(2):263–266
Coppola D, Fu L, Nicosia SV, Kounelis S, Jones M (1998) Prognostic significance of p53, bcl-2, vimentin, and S100 protein-positive Langerhans cells in endometrial carcinoma. Hum Pathol 29(5):455–462
Coronella-Wood JA, Hersh EM (2003) Naturally occurring B-cell responses to breast cancer. Cancer Immunol Immunother 52(12):715–738
Coussens LM, Werb Z (1996) Matrix metalloproteinases and the development of cancer. Chem Biol 3(11):895–904
Coussens LM, Werb Z (2001) Inflammatory cells and cancer: think different! J Exp Med 193(6):F23–F26
Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420(6917):860–867
Coussens LM, Raymond WW, Bergers G et al (1999) Inflammatory mast cells up-regulate angiogenesis during squamous epithelial carcinogenesis. Genes Dev 13(11):1382–1397
Coussens LM, Tinkle CL, Hanahan D, Werb Z (2000) MMP-9 supplied by bone marrow-derived cells contributes to skin carcinogenesis. Cell 103(3):481–490
Coventry BJ, Morton J (2003) CD1a-positive infiltrating-dendritic cell density and 5-year survival from human breast cancer. Br J Cancer 89(3):533–538
Coventry BJ, Lee PL, Gibbs D, Hart DN (2002) Dendritic cell density and activation status in human breast cancer—CD1a, CMRF-44, CMRF-56 and CD-83 expression. Br J Cancer 86(4):546–551
Crivellato E, Nico B, Ribatti D (2009) Mast cell contribution to tumor angiogenesis: a clinical approach. Eur Cytokine Netw 20(4):197–206
Curiel TJ, Coukos G, Zou L et al (2004) Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat Med 10(9):942–949
Dabiri S, Huntsman D, Makretsov N et al (2004) The presence of stromal mast cells identifies a subset of invasive breast cancers with a favorable prognosis. Mod Pathol 17(6):690–695
Dadabayev AR, Sandel MH, Menon AG et al (2004) Dendritic cells in colorectal cancer correlate with other tumor-infiltrating immune cells. Cancer Immunol Immunother 53(11):978–986
Dai F, Liu L, Che G et al (2010) The number and microlocalization of tumor-associated immune cells are associated with patient’s survival time in non-small cell lung cancer. BMC Cancer 10:220
Dallal RM, Christakos P, Lee K, Egawa S, Son YI, Lotze MT (2002) Paucity of dendritic cells in pancreatic cancer. Surgery 131(2):135–138
Dallegri F, Ottonello L, Ballestrero A et al (1991) Tumor cell lysis by activated human neutrophils: analysis of neutrophil-delivered oxidative attack and role of leukocyte function-associated antigen 1. Inflammation 15(1):15–30
De Monte L, Reni M, Tassi E et al (2011) Intratumor T helper type 2 cell infiltrate correlates with cancer-associated fibroblast thymic stromal lymphopoietin production and reduced survival in pancreatic cancer. J Exp Med 208(3):469–478
De Palma M, Venneri MA, Galli R et al (2005) Tie2 identifies a hematopoietic lineage of proangiogenic monocytes required for tumor vessel formation and a mesenchymal population of pericyte progenitors. Cancer Cell 8(3):211–226
De Panfilis G, Campanini N, Santini M et al (2008) Phase- and stage-related proportions of T cells bearing the transcription factor FOXP3 infiltrate primary melanoma. J Invest Dermatol 128(3):676–684
de Visser KE, Eichten A, Coussens LM (2006) Paradoxical roles of the immune system during cancer development. Nat Rev 6(1):24–37
Degli-Esposti MA, Smyth MJ (2005) Close encounters of different kinds: dendritic cells and NK cells take centre stage. Nat Rev Immunol 5(2):112–124
Della Porta M, Danova M, Rigolin GM et al (2005) Dendritic cells and vascular endothelial growth factor in colorectal cancer: correlations with clinicobiological findings. Oncology 68(2–3):276–284
Di Carlo E, Coletti A, Modesti A, Giovarelli M, Forni G, Musiani P (1998) Local release of interleukin-10 by transfected mouse adenocarcinoma cells exhibits pro- and anti-inflammatory activity and results in a delayed tumor rejection. Eur Cytokine Netw 9(1):61–68
Di Carlo E, Forni G, Lollini P, Colombo MP, Modesti A, Musiani P (2001) The intriguing role of polymorphonuclear neutrophils in antitumor reactions. Blood 97(2):339–345
Di Santo JP (2008) Natural killer cells: diversity in search of a niche. Nat Immunol 9(5):473–475
Diederichsen AC, Hjelmborg JB, Christensen PB, Zeuthen J, Fenger C (2003) Prognostic value of the CD4+/CD8+ ratio of tumour infiltrating lymphocytes in colorectal cancer and HLA-DR expression on tumour cells. Cancer Immunol Immunother 52(7):423–428
Dieu-Nosjean MC, Antoine M, Danel C et al (2008) Long-term survival for patients with non-small-cell lung cancer with intratumoral lymphoid structures. J Clin Oncol 26(27):4410–4417
Dorta RG, Landman G, Kowalski LP, Lauris JR, Latorre MR, Oliveira DT (2002) Tumour-associated tissue eosinophilia as a prognostic factor in oral squamous cell carcinomas. Histopathology 41(2):152–157
Doubrovina ES, Doubrovin MM, Vider E et al (2003) Evasion from NK cell immunity by MHC class I chain-related molecules expressing colon adenocarcinoma. J Immunol 171(12):6891–6899
Dunn GP, Koebel CM, Schreiber RD (2006) Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6(11):836–848
Ebrahem Q, Chaurasia SS, Vasanji A et al (2010) Cross-talk between vascular endothelial growth factor and matrix metalloproteinases in the induction of neovascularization in vivo. Am J Pathol 176(1):496–503
Eck M, Schmausser B, Scheller K, Brandlein S, Muller-Hermelink HK (2003) Pleiotropic effects of CXC chemokines in gastric carcinoma: differences in CXCL8 and CXCL1 expression between diffuse and intestinal types of gastric carcinoma. Clin Exp Immunol 134(3):508–515
Edge SB (ed) (2010) AJCC cancer staging manual/American Joint Committee on Cancer, 7th edn. Springer, New York
Elpek GO, Gelen T, Aksoy NH et al (2001) The prognostic relevance of angiogenesis and mast cells in squamous cell carcinoma of the oesophagus. J Clin Pathol 54(12):940–944
Esendagli G, Bruderek K, Goldmann T et al (2008) Malignant and non-malignant lung tissue areas are differentially populated by natural killer cells and regulatory T cells in non-small cell lung cancer. Lung cancer (Amsterdam, Netherlands) 59(1): 32–40
Espinosa I, Jose Carnicer M, Catasus L et al (2010) Myometrial invasion and lymph node metastasis in endometrioid carcinomas: tumor-associated macrophages, microvessel density, and HIF1A have a crucial role. Am J Surg Pathol 34(11):1708–1714
Esposito I, Menicagli M, Funel N et al (2004) Inflammatory cells contribute to the generation of an angiogenic phenotype in pancreatic ductal adenocarcinoma. J Clin Pathol 57(6):630–636
Feijoo E, Alfaro C, Mazzolini G et al (2005) Dendritic cells delivered inside human carcinomas are sequestered by interleukin-8. Int J Cancer 116(2):275–281
Fischer C, Jonckx B, Mazzone M et al (2007) Anti-PlGF inhibits growth of VEGF(R)-inhibitor-resistant tumors without affecting healthy vessels. Cell 131(3):463–475
Focosi D, Bestagno M, Burrone O, Petrini M (2010) CD57+ T lymphocytes and functional immune deficiency. J Leukoc Biol 87(1):107–116
Frederick MJ, Henderson Y, Xu X et al (2000) In vivo expression of the novel CXC chemokine BRAK in normal and cancerous human tissue. Am J Pathol 156(6):1937–1950
French AR, Yokoyama WM (2003) Natural killer cells and viral infections. Curr Opin Immunol 15(1):45–51
Fujii M, Yamashita T, Ishiguro R, Tashiro M, Kameyama K (2002) Significance of epidermal growth factor receptor and tumor associated tissue eosinophilia in the prognosis of patients with nasopharyngeal carcinoma. Auris Nasus Larynx 29(2):175–181
Funada Y, Noguchi T, Kikuchi R, Takeno S, Uchida Y, Gabbert HE (2003) Prognostic significance of CD8 + T cell and macrophage peritumoral infiltration in colorectal cancer. Oncol Rep 10(2):309–313
Furihata M, Ono Y, Ichikawa K, Tomita S, Fujimori T, Kubota K (2005) Prognostic significance of CD83 positive, mature dendritic cells in the gallbladder carcinoma. Oncol Rep 14(2):353–356
Gabrilovich D (2004) Mechanisms and functional significance of tumour-induced dendritic-cell defects. Nat Rev Immunol 4(12):941–952
Gabrilovich DI, Chen HL, Girgis KR et al (1996) Production of vascular endothelial growth factor by human tumors inhibits the functional maturation of dendritic cells. Nat Med 2(10):1096–1103
Galon J, Costes A, Sanchez-Cabo F et al (2006) Type, density, and location of immune cells within human colorectal tumors predict clinical outcome. Science (New York) 313(5795): 1960–1964
Gao Q, Qiu SJ, Fan J et al (2007) Intratumoral balance of regulatory and cytotoxic T cells is associated with prognosis of hepatocellular carcinoma after resection. J Clin Oncol 25(18):2586–2593
Giraudo E, Inoue M, Hanahan D (2004) An amino-bisphosphonate targets MMP-9-expressing macrophages and angiogenesis to impair cervical carcinogenesis. J Clin Investig 114(5):623–633
Goldsmith MM, Belchis DA, Cresson DH, Merritt WD 3rd, Askin FB (1992) The importance of the eosinophil in head and neck cancer. Otolaryngol Head Neck Surg 106(1):27–33
Gooch JL, Lee AV, Yee D (1998) Interleukin 4 inhibits growth and induces apoptosis in human breast cancer cells. Cancer Res 58(18):4199–4205
Gooden MJ, de Bock GH, Leffers N, Daemen T, Nijman HW (2011) The prognostic influence of tumour-infiltrating lymphocytes in cancer: a systematic review with meta-analysis. Br J Cancer 105(1):93–103
Gordon S (2003) Alternative activation of macrophages. Nat Rev Immunol 3(1):23–35
Gounaris E, Erdman SE, Restaino C et al (2007) Mast cells are an essential hematopoietic component for polyp development. Proc Natl Acad Sci USA 104(50):19977–19982
Gregory AD, Houghton AM (2011) Tumor-associated neutrophils: new targets for cancer therapy. Cancer Res 71(7):2411–2416
Griffiths AP, Rice A, Dixon MF (1998) Anaplastic gastric adenocarcinoma with extensive neutrophilic infiltration. Histopathology 33(4):392–393
Grimbaldeston MA, Metz M, Yu M, Tsai M, Galli SJ (2006) Effector and potential immunoregulatory roles of mast cells in IgE-associated acquired immune responses. Curr Opin Immunol 18(6):751–760
Grutzkau A, Kruger-Krasagakes S, Baumeister H et al (1998) Synthesis, storage, and release of vascular endothelial growth factor/vascular permeability factor (VEGF/VPF) by human mast cells: implications for the biological significance of VEGF206. Mol Biol Cell 9(4):875–884
Gulubova M, Vlaykova T (2009) Prognostic significance of mast cell number and microvascular density for the survival of patients with primary colorectal cancer. J Gastroenterol Hepatol 24(7):1265–1275
Hartmann E, Wollenberg B, Rothenfusser S et al (2003) Identification and functional analysis of tumor-infiltrating plasmacytoid dendritic cells in head and neck cancer. Cancer Res 63(19):6478–6487
Hashimoto SI, Suzuki T, Nagai S, Yamashita T, Toyoda N, Matsushima K (2000) Identification of genes specifically expressed in human activated and mature dendritic cells through serial analysis of gene expression. Blood 96(6):2206–2214
Hayati AR, Zulkarnaen M (2007) An immunohistochemical study of CD1a and CD83-positive infiltrating dendritic cell density in cervical neoplasia. Int J Gynecol Pathol 26(1):83–88
Hillen F, Baeten CI, van de Winkel A et al (2008) Leukocyte infiltration and tumor cell plasticity are parameters of aggressiveness in primary cutaneous melanoma. Cancer Immunol Immunother 57(1):97–106
Hillenbrand EE, Neville AM, Coventry BJ (1999) Immunohistochemical localization of CD1a-positive putative dendritic cells in human breast tumours. Br J Cancer 79(5–6):940–944
Hiraoka K, Miyamoto M, Cho Y et al (2006) Concurrent infiltration by CD8+ T cells and CD4+ T cells is a favourable prognostic factor in non-small-cell lung carcinoma. Br J Cancer 94(2):275–280
Hoeffel G, Ripoche AC, Matheoud D et al (2007) Antigen crosspresentation by human plasmacytoid dendritic cells. Immunity 27(3):481–492
Hori S, Nomura T, Sakaguchi S (2003) Control of regulatory T cell development by the transcription factor Foxp3. Science (New York) 299(5609): 1057–1061
Houghton AM (2010) The paradox of tumor-associated neutrophils: fueling tumor growth with cytotoxic substances. Cell cycle (Georgetown, Tex) 9(9):1732–1737
Houghton AM, Rzymkiewicz DM, Ji H et al (2010) Neutrophil elastase-mediated degradation of IRS-1 accelerates lung tumor growth. Nat Med 16(2):219–223
Hromas R, Broxmeyer HE, Kim C et al (1999) Cloning of BRAK, a novel divergent CXC chemokine preferentially expressed in normal versus malignant cells. Biochem Biophys Res Commun 255(3):703–706
Huang B, Lei Z, Zhang GM et al (2008) SCF-mediated mast cell infiltration and activation exacerbate the inflammation and immunosuppression in tumor microenvironment. Blood 112(4):1269–1279
Hubert P, Caberg JH, Gilles C et al (2005) E-cadherin-dependent adhesion of dendritic and Langerhans cells to keratinocytes is defective in cervical human papillomavirus-associated (pre)neoplastic lesions. J Pathol 206(3):346–355
Humphreys TR, Monteiro MR, Murphy GF (2000) Mast cells and dendritic cells in basal cell carcinoma stroma. Dermatol Surg 26(3):200–203; discussion 3–4
Hussein MR, Elsers DA, Fadel SA, Omar AE (2006) Immunohistological characterisation of tumour infiltrating lymphocytes in melanocytic skin lesions. J Clin Pathol 59(3):316–324
Iamaroon A, Pongsiriwet S, Jittidecharaks S, Pattanaporn K, Prapayasatok S, Wanachantararak S (2003) Increase of mast cells and tumor angiogenesis in oral squamous cell carcinoma. J Oral Pathol Med 32(4):195–199
Ichihara F, Kono K, Takahashi A, Kawaida H, Sugai H, Fujii H (2003) Increased populations of regulatory T cells in peripheral blood and tumor-infiltrating lymphocytes in patients with gastric and esophageal cancers. Clin Cancer Res 9(12):4404–4408
Inoshima N, Nakanishi Y, Minami T et al (2002) The influence of dendritic cell infiltration and vascular endothelial growth factor expression on the prognosis of non-small cell lung cancer. Clin Cancer Res 8(11):3480–3486
Inoue K, Furihata M, Ohtsuki Y, Fujita Y (1993) Distribution of S-100 protein-positive dendritic cells and expression of HLA-DR antigen in transitional cell carcinoma of the urinary bladder in relation to tumour progression and prognosis. Virchows Arch 422(5):351–355
Ioachim-Velogianni E, Stavropoulos NE, Kitsiou E, Stefanaki S, Agnantis NJ (1995) Distribution of CD1a-positive Langerhans cells and lymphocyte subsets in transitional cell carcinoma of the urinary bladder. An immunohistological study on frozen sections. J Pathol 177(4):401–406
Ishibashi S, Ohashi Y, Suzuki T et al (2006a) Tumor-associated tissue eosinophilia in human esophageal squamous cell carcinoma. Anticancer Res 26(2B):1419–1424
Ishibashi Y, Tanaka S, Tajima K, Yoshida T, Kuwano H (2006b) Expression of Foxp3 in non-small cell lung cancer patients is significantly higher in tumor tissues than in normal tissues, especially in tumors smaller than 30 mm. Oncol Rep 15(5):1315–1319
Ishigami S, Natsugoe S, Tokuda K et al (2000a) Clinical impact of intratumoral natural killer cell and dendritic cell infiltration in gastric cancer. Cancer Lett 159(1):103–108
Ishigami S, Natsugoe S, Tokuda K et al (2000b) Prognostic value of intratumoral natural killer cells in gastric carcinoma. Cancer 88(3):577–583
Ito T, Yang M, Wang YH et al (2007) Plasmacytoid dendritic cells prime IL-10-producing T regulatory cells by inducible costimulator ligand. J Exp Med 204(1):105–115
Iwamoto M, Shinohara H, Miyamoto A et al (2003) Prognostic value of tumor-infiltrating dendritic cells expressing CD83 in human breast carcinomas. Int J Cancer 104(1):92–97
Jahrsdorfer B, Vollmer A, Blackwell SE et al (2010) Granzyme B produced by human plasmacytoid dendritic cells suppresses T-cell expansion. Blood 115(6):1156–1165
Jensen HK, Donskov F, Marcussen N, Nordsmark M, Lundbeck F, von der Maase H (2009) Presence of intratumoral neutrophils is an independent prognostic factor in localized renal cell carcinoma. J Clin Oncol 27(28):4709–4717
Ji H, Houghton AM, Mariani TJ et al (2006) K-ras activation generates an inflammatory response in lung tumors. Oncogene 25(14):2105–2112
Jia J, Wang Z, Li X, Wang Z, Wang X (2012) Morphological characteristics and co-stimulatory molecule (CD80, CD86, CD40) expression in tumor infiltrating dendritic cells in human endometrioid adenocarcinoma. Eur J Obstet Gynecol Reprod Biol 160(2):223–227
Jodele S, Chantrain CF, Blavier L et al (2005) The contribution of bone marrow-derived cells to the tumor vasculature in neuroblastoma is matrix metalloproteinase-9 dependent. Cancer Res 65(8):3200–3208
Johnson SK, Kerr KM, Chapman AD et al (2000) Immune cell infiltrates and prognosis in primary carcinoma of the lung. Lung Cancer (Amsterdam, Netherlands) 27(1): 27–35
Jordanova ES, Gorter A, Ayachi O et al (2008) Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients? Clin Cancer Res 14(7):2028–2035
Juremalm M, Nilsson G (2005) Chemokine receptor expression by mast cells. Chem Immunol Allergy 87:130–144
Kang JC, Chen JS, Lee CH, Chang JJ, Shieh YS (2010) Intratumoral macrophage counts correlate with tumor progression in colorectal cancer. J Surg Oncol 102(3):242–248
Kaplan RN, Riba RD, Zacharoulis S et al (2005) VEGFR1-positive haematopoietic bone marrow progenitors initiate the pre-metastatic niche. Nature 438(7069):820–827
Karja V, Aaltomaa S, Lipponen P, Isotalo T, Talja M, Mokka R (2005) Tumour-infiltrating lymphocytes: a prognostic factor of PSA-free survival in patients with local prostate carcinoma treated by radical prostatectomy. Anticancer Res 25(6C):4435–4438
Karre K (2002) NK cells, MHC class I molecules and the missing self. Scand J Immunol 55(3):221–228
Katsenelson NS, Shurin GV, Bykovskaia SN, Shogan J, Shurin MR (2001) Human small cell lung carcinoma and carcinoid tumor regulate dendritic cell maturation and function. Mod Pathol 14(1):40–45
Kawahara A, Hattori S, Akiba J et al (2010) Infiltration of thymidine phosphorylase-positive macrophages is closely associated with tumor angiogenesis and survival in intestinal type gastric cancer. Oncol Rep 24(2):405–415
Kawai O, Ishii G, Kubota K et al (2008) Predominant infiltration of macrophages and CD8(+) T Cells in cancer nests is a significant predictor of survival in stage IV nonsmall cell lung cancer. Cancer 113(6):1387–1395
Kessenbrock K, Plaks V, Werb Z (2010) Matrix metalloproteinases: regulators of the tumor microenvironment. Cell 141(1):52–67
Khorana AA, Ryan CK, Cox C, Eberly S, Sahasrabudhe DM (2003) Vascular endothelial growth factor, CD68, and epidermal growth factor receptor expression and survival in patients with stage II and Stage III colon carcinoma: a role for the host response in prognosis. Cancer 97(4):960–968
Kikuchi K, Kusama K, Taguchi K et al (2002) Dendritic cells in human squamous cell carcinoma of the oral cavity. Anticancer Res 22(2A):545–557
Kluger HM, Dolled-Filhart M, Rodov S, Kacinski BM, Camp RL, Rimm DL (2004) Macrophage colony-stimulating factor-1 receptor expression is associated with poor outcome in breast cancer by large cohort tissue microarray analysis. Clin Cancer Res 10(1 Pt 1):173–177
Komohara Y, Hasita H, Ohnishi K et al (2011) Macrophage infiltration and its prognostic relevance in clear cell renal cell carcinoma. Cancer Sci 102(7):1424–1431
Kondo K, Muramatsu M, Okamoto Y et al (2006) Expression of chymase-positive cells in gastric cancer and its correlation with the angiogenesis. J Surg Oncol 93(1):36–42; discussion-3
Kondratiev S, Sabo E, Yakirevich E, Lavie O, Resnick MB (2004) Intratumoral CD8+ T lymphocytes as a prognostic factor of survival in endometrial carcinoma. Clin Cancer Res 10(13):4450–4456
Kurabayashi A, Furihata M, Matsumoto M, Hayashi H, Ohtsuki Y (2004) Distribution of tumor-infiltrating dendritic cells in human non-small cell lung carcinoma in relation to apoptosis. Pathol Int 54(5):302–310
Kurahara H, Shinchi H, Mataki Y et al (2009) Significance of M2-polarized tumor-associated macrophage in pancreatic cancer. J Surg Res 167(2):e211–e219
Labidi-Galy SI, Sisirak V, Meeus P et al (2011) Quantitative and functional alterations of plasmacytoid dendritic cells contribute to immune tolerance in ovarian cancer. Cancer Res 71(16):5423–5434
Ladanyi A, Somlai B, Gilde K, Fejos Z, Gaudi I, Timar J (2004) T-cell activation marker expression on tumor-infiltrating lymphocytes as prognostic factor in cutaneous malignant melanoma. Clin Cancer Res 10(2):521–530
Ladanyi A, Kiss J, Somlai B et al (2007) Density of DC-LAMP(+) mature dendritic cells in combination with activated T lymphocytes infiltrating primary cutaneous melanoma is a strong independent prognostic factor. Cancer Immunol Immunother 56(9):1459–1469
Ladanyi A, Mohos A, Somlai B et al (2010) FOXP3+ cell density in primary tumor has no prognostic impact in patients with cutaneous malignant melanoma. Pathol Oncol Res 16(3):303–309
Lee TK, Horner RD, Silverman JF, Chen YH, Jenny C, Scarantino CW (1989) Morphometric and morphologic evaluations in stage III non-small cell lung cancers. Prognostic significance of quantitative assessment of infiltrating lymphoid cells. Cancer 63(2):309–316
Lee CH, Espinosa I, Vrijaldenhoven S et al (2008) Prognostic significance of macrophage infiltration in leiomyosarcomas. Clin Cancer Res 14(5):1423–1430
Lespagnard L, Gancberg D, Rouas G et al (1999) Tumor-infiltrating dendritic cells in adenocarcinomas of the breast: a study of 143 neoplasms with a correlation to usual prognostic factors and to clinical outcome. Int J Cancer 84(3):309–314
Lewis CE, Pollard JW (2006) Distinct role of macrophages in different tumor microenvironments. Cancer Res 66(2):605–612
Li YW, Qiu SJ, Fan J et al (2009a) Tumor-infiltrating macrophages can predict favorable prognosis in hepatocellular carcinoma after resection. J Cancer Res Clin Oncol 135(3):439–449
Li JF, Chu YW, Wang GM et al (2009b) The prognostic value of peritumoral regulatory T cells and its correlation with intratumoral cyclooxygenase-2 expression in clear cell renal cell carcinoma. BJU Int 103(3):399–405
Lim KH, Telisinghe PU, Abdullah MS, Ramasamy R (2010) Possible significance of differences in proportions of cytotoxic T cells and B-lineage cells in the tumour-infiltrating lymphocytes of typical and atypical medullary carcinomas of the breast. Cancer Immun 10:3
Liu YJ (2005) IPC: professional type 1 interferon-producing cells and plasmacytoid dendritic cell precursors. Annu Rev Immunol 23:275–306
Liu K, Victora GD, Schwickert TA et al (2009) In vivo analysis of dendritic cell development and homeostasis. Science (New York, NY) 324(5925):392–397
Liyanage UK, Moore TT, Joo HG et al (2002) Prevalence of regulatory T cells is increased in peripheral blood and tumor microenvironment of patients with pancreas or breast adenocarcinoma. J Immunol 169(5):2756–2761
Lowe DG (1988) Carcinoma of the cervix with massive eosinophilia. Br J Obstet Gynaecol 95(4):393–401
Lowe D, Jorizzo J, Hutt MS (1981a) Tumour-associated eosinophilia: a review. J Clin Pathol 34(12):1343–1348
Lowe D, Jorizzo J, Chiphangwi J, Hutt MS (1981b) Cervical carcinoma in Malawi: a histopathologic study of 260 cases. Cancer 47(10):2493–2495
Lundy SK, Killer B (2009) Lymphocytes: the evidence and the potential. Inflamm Res 58(7):345–357
Ma XL, Weyrich AS, Lefer DJ, Lefer AM (1993) Diminished basal nitric oxide release after myocardial ischemia and reperfusion promotes neutrophil adherence to coronary endothelium. Circ Res 72(2):403–412
Ma J, Liu L, Che G, Yu N, Dai F, You Z (2010) The M1 form of tumor-associated macrophages in non-small cell lung cancer is positively associated with survival time. BMC cancer 10:112
Ma Y, Shurin GV, Gutkin DW, Shurin MR (2012) Tumor associated regulatory dendritic cells. Semin Cancer Biol 22(4):298–306
Maltby S, Khazaie K, McNagny KM (2009) Mast cells in tumor growth: angiogenesis, tissue remodelling and immune-modulation. Biochim Biophys Acta 1796(1):19–26
Mantovani A, Sozzani S, Locati M, Allavena P, Sica A (2002) Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes. Trends Immunol 23(11):549–555
Mantovani A, Sica A, Sozzani S, Allavena P, Vecchi A, Locati M (2004) The chemokine system in diverse forms of macrophage activation and polarization. Trends Immunol 25(12):677–686
Mantovani A, Sica A, Locati M (2005) Macrophage polarization comes of age. Immunity 23(4):344–346
Mantovani A, Sica A, Locati M (2007) New vistas on macrophage differentiation and activation. Eur J Immunol 37(1):14–16
Marcus B, Arenberg D, Lee J et al (2004) Prognostic factors in oral cavity and oropharyngeal squamous cell carcinoma. Cancer 101(12):2779–2787
Marsigliante S, Biscozzo L, Marra A et al (1999) Computerised counting of tumour infiltrating lymphocytes in 90 breast cancer specimens. Cancer Lett 139(1):33–41
Matta BM, Castellaneta A, Thomson AW (2010) Tolerogenic plasmacytoid DC. Eur J Immunol 40(10):2667–2676
Mazzucchelli L, Loetscher P, Kappeler A et al (1996) Monocyte chemoattractant protein-1 gene expression in prostatic hyperplasia and prostate adenocarcinoma. Am J Pathology 149(2):501–509
Meininger CJ (1995) Mast cells and tumor-associated angiogenesis. Chem Immunol 62:239–257
Meininger CJ, Yano H, Rottapel R, Bernstein A, Zsebo KM, Zetter BR (1992) The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 79(4):958–963
Michielsen AJ, Hogan AE, Marry J et al (2011) Tumour tissue microenvironment can inhibit dendritic cell maturation in colorectal cancer. PLoS ONE 6(11):e27944
Milne K, Kobel M, Kalloger SE et al (2009) Systematic analysis of immune infiltrates in high-grade serous ovarian cancer reveals CD20, FoxP3 and TIA-1 as positive prognostic factors. PLoS ONE 4(7):e6412
Mimura K, Kono K, Takahashi A, Kawaguchi Y, Fujii H (2007) Vascular endothelial growth factor inhibits the function of human mature dendritic cells mediated by VEGF receptor-2. Cancer Immunol Immunother 56(6):761–770
Miracco C, Mourmouras V, Biagioli M et al (2007) Utility of tumour-infiltrating CD25+ FOXP3+ regulatory T cell evaluation in predicting local recurrence in vertical growth phase cutaneous melanoma. Oncol Rep 18(5):1115–1122
Miyagawa S, Soeda J, Takagi S, Miwa S, Ichikawa E, Noike T (2004) Prognostic significance of mature dendritic cells and factors associated with their accumulation in metastatic liver tumors from colorectal cancer. Hum Pathol 35(11):1392–1396
Moezzi J, Gopalswamy N, Haas RJ Jr, Markert RJ, Suryaprasad S, Bhutani MS (2000) Stromal eosinophilia in colonic epithelial neoplasms. Am J Gastroenterol 95(2):520–523
Moretta L, Bottino C, Pende D, Mingari MC, Biassoni R, Moretta A (2002) Human natural killer cells: their origin, receptors and function. Eur J Immunol 32(5):1205–1211
Moretta L, Ferlazzo G, Mingari MC, Melioli G, Moretta A (2003) Human natural killer cell function and their interactions with dendritic cells. Vaccine 21(Suppl 2):S38–S42
Mori M, Ohtani H, Naito Y et al (2000) Infiltration of CD8+ T cells in non-small cell lung cancer is associated with dedifferentiation of cancer cells, but not with prognosis. Tohoku J Exp Med 191(2):113–118
Mosser DM, Edwards JP (2008) Exploring the full spectrum of macrophage activation. Nat Rev Immunol 8(12):958–969
Mouries J, Moron G, Schlecht G, Escriou N, Dadaglio G, Leclerc C (2008) Plasmacytoid dendritic cells efficiently cross-prime naive T cells in vivo after TLR activation. Blood 112(9):3713–3722
Muller AJ, Prendergast GC (2007) Indoleamine 2, 3-dioxygenase in immune suppression and cancer. Curr Cancer Drug Targets 7(1):31–40
Murdoch C, Muthana M, Coffelt SB, Lewis CE (2008) The role of myeloid cells in the promotion of tumour angiogenesis. Nat Rev 8(8):618–631
Musiani P, Allione A, Modica A et al (1996) Role of neutrophils and lymphocytes in inhibition of a mouse mammary adenocarcinoma engineered to release IL-2, IL-4, IL-7, IL-10, IFN-alpha, IFN-gamma, and TNF-alpha. Lab Invest; J Tech Methods Pathol 74(1):146–157
Nagorsen D, Voigt S, Berg E, Stein H, Thiel E, Loddenkemper C (2007) Tumor-infiltrating macrophages and dendritic cells in human colorectal cancer: relation to local regulatory T cells, systemic T-cell response against tumor-associated antigens and survival. J Transl Med 5:62
Naik SH, Sathe P, Park HY et al (2007) Development of plasmacytoid and conventional dendritic cell subtypes from single precursor cells derived in vitro and in vivo. Nat Immunol 8(11):1217–1226
Naito Y, Saito K, Shiiba K et al (1998) CD8+ T cells infiltrated within cancer cell nests as a prognostic factor in human colorectal cancer. Cancer Res 58(16):3491–3494
Nakajima T, Kodama T, Tsumuraya M, Shimosato Y, Kameya T (1985) S-100 protein-positive Langerhans cells in various human lung cancers, especially in peripheral adenocarcinomas. Virchows Arch 407(2):177–189
Nakakubo Y, Miyamoto M, Cho Y et al (2003) Clinical significance of immune cell infiltration within gallbladder cancer. Br J Cancer 89(9):1736–1742
Nakayama Y, Inoue Y, Minagawa N et al (2003) Relationships between S-100 protein-positive cells and clinicopathological factors in patients with colorectal cancer. Anticancer Res 23(6a):4423–4426
Nakayama T, Yao L, Tosato G (2004) Mast cell-derived angiopoietin-1 plays a critical role in the growth of plasma cell tumors. J Clin Investig 114(9):1317–1325
Nedergaard BS, Ladekarl M, Nyengaard JR, Nielsen K (2008) A comparative study of the cellular immune response in patients with stage IB cervical squamous cell carcinoma. Low numbers of several immune cell subtypes are strongly associated with relapse of disease within 5 years. Gynecol Oncol 108(1):106–111
Negus RP, Stamp GW, Relf MG et al (1995) The detection and localization of monocyte chemoattractant protein-1 (MCP-1) in human ovarian cancer. J Clin Investig 95(5):2391–2396
Nelson BH (2008) The impact of T-cell immunity on ovarian cancer outcomes. Immunol Rev 222:101–116
Nelson BH (2010) CD20+ B cells: the other tumor-infiltrating lymphocytes. J Immunol 185(9):4977–4982
Nielsen HJ, Hansen U, Christensen IJ, Reimert CM, Brunner N, Moesgaard F (1999) Independent prognostic value of eosinophil and mast cell infiltration in colorectal cancer tissue. J Pathol 189(4):487–495
Norian LA, Rodriguez PC, O’Mara LA et al (2009) Tumor-infiltrating regulatory dendritic cells inhibit CD8+ T cell function via l-arginine metabolism. Cancer Res 69(7):3086–3094
Norrby K (2002) Mast cells and angiogenesis. Apmis 110(5):355–371
Nosho K, Baba Y, Tanaka N et al (2010) Tumour-infiltrating T-cell subsets, molecular changes in colorectal cancer, and prognosis: cohort study and literature review. J Pathol 222(4):350–366
Oble DA, Loewe R, Yu P, Mihm MC Jr (2009) Focus on TILs: prognostic significance of tumor infiltrating lymphocytes in human melanoma. Cancer Immun 9:3
O’Donnell RK, Mick R, Feldman M et al (2007) Distribution of dendritic cell subtypes in primary oral squamous cell carcinoma is inconsistent with a functional response. Cancer Lett 255(1):145–152
Ohri CM, Shikotra A, Green RH, Waller DA, Bradding P (2009) Macrophages within NSCLC tumour islets are predominantly of a cytotoxic M1 phenotype associated with extended survival. Eur Respir J 33(1):118–126
Ohtaki Y, Ishii G, Nagai K et al (2010) Stromal macrophage expressing CD204 is associated with tumor aggressiveness in lung adenocarcinoma. J Thorac Oncol 5(10):1507–1515
Okayama Y, Ono Y, Nakazawa T, Church MK, Mori M (1998) Human skin mast cells produce TNF-alpha by substance P. Int Arch Allergy Immunol 117(Suppl 1):48–51
Ono Y, Ozawa M, Tamura Y et al (2002) Tumor-associated tissue eosinophilia of penile cancer. Int J Urol 9(2):82–87
Orange JS, Ballas ZK (2006) Natural killer cells in human health and disease. Clin Immunol (Orlando, Fla) 118(1): 1–10
Osada T, Chong G, Tansik R et al (2008) The effect of anti-VEGF therapy on immature myeloid cell and dendritic cells in cancer patients. Cancer Immunol Immunother 57(8):1115–1124
Oshikiri T, Miyamoto M, Shichinohe T et al (2003) Prognostic value of intratumoral CD8+ T lymphocyte in extrahepatic bile duct carcinoma as essential immune response. J Surg Oncol 84(4):224–228
Pages F, Galon J, Dieu-Nosjean MC, Tartour E, Sautes-Fridman C, Fridman WH (2010) Immune infiltration in human tumors: a prognostic factor that should not be ignored. Oncogene 29(8):1093–1102
Pandit R, Scholnik A, Wulfekuhler L, Dimitrov N (2007) Non-small-cell lung cancer associated with excessive eosinophilia and secretion of interleukin-5 as a paraneoplastic syndrome. Am J Hematol 82(3):234–237
Papamichail M, Perez SA, Gritzapis AD, Baxevanis CN (2004) Natural killer lymphocytes: biology, development, and function. Cancer Immunol Immunother 53(3):176–186
Park MH, Lee JS, Yoon JH (2012) High expression of CX3CL1 by tumor cells correlates with a good prognosis and increased tumor-infiltrating CD8+ T cells, natural killer cells, and dendritic cells in breast carcinoma. J Surg Oncol 106(4):386–392
Passlick B, Pantel K, Kubuschok B et al (1996) Expression of MHC molecules and ICAM-1 on non-small cell lung carcinomas: association with early lymphatic spread of tumour cells. Eur J Cancer 32A(1):141–145
Pekarek LA, Starr BA, Toledano AY, Schreiber H (1995) Inhibition of tumor growth by elimination of granulocytes. J Exp Med 181(1):435–440
Pelletier MP, Edwardes MD, Michel RP, Halwani F, Morin JE (2001) Prognostic markers in resectable non-small cell lung cancer: a multivariate analysis. Can J Surg 44(3):180–188
Peng SH, Deng H, Yang JF et al (2005) Significance and relationship between infiltrating inflammatory cell and tumor angiogenesis in hepatocellular carcinoma tissues. World J Gastroenterol 11(41):6521–6524
Penna G, Vulcano M, Roncari A, Facchetti F, Sozzani S, Adorini L (2002) Cutting edge: differential chemokine production by myeloid and plasmacytoid dendritic cells. J Immunol 169(12):6673–6676
Perez SA, Karamouzis MV, Skarlos DV et al (2007) CD4+CD25+ regulatory T-cell frequency in HER-2/neu (HER)-positive and HER-negative advanced-stage breast cancer patients. Clin Cancer Res 13(9):2714–2721
Perussia B (1996) The cytokine profile of resting and activated NK cells. Methods (San Diego, Calif) 9(2): 370–378
Petersen RP, Campa MJ, Sperlazza J et al (2006) Tumor infiltrating Foxp3+ regulatory T-cells are associated with recurrence in pathologic stage I NSCLC patients. Cancer 107(12):2866–2872
Pollard JW (2004) Tumour-educated macrophages promote tumour progression and metastasis. Nat Rev 4(1):71–78
Pretlow TP, Keith EF, Cryar AK et al (1983) Eosinophil infiltration of human colonic carcinomas as a prognostic indicator. Cancer Res 43(6):2997–3000
Punt CJ, Barbuto JA, Zhang H, Grimes WJ, Hatch KD, Hersh EM (1994) Anti-tumor antibody produced by human tumor-infiltrating and peripheral blood B lymphocytes. Cancer Immunol Immunother 38(4):225–232
Purdy AK, Campbell KS (2009) Natural killer cells and cancer: regulation by the killer cell Ig-like receptors (KIR). Cancer Biol Ther 8(23):2211–2220
Qu Z, Huang X, Ahmadi P et al (1998) Synthesis of basic fibroblast growth factor by murine mast cells. Regulation by transforming growth factor beta, tumor necrosis factor alpha, and stem cell factor. Int Arch Allergy Immunol 115(1):47–54
Rajput AB, Turbin DA, Cheang MC et al (2008) Stromal mast cells in invasive breast cancer are a marker of favourable prognosis: a study of 4,444 cases. Breast Cancer Res Treat 107(2):249–257
Ralfkiaer E, Hou-Jensen K, Gatter KC, Drzewiecki KT, Mason DY (1987) Immunohistological analysis of the lymphoid infiltrate in cutaneous malignant melanomas. Virchows Arch 410(4):355–361
Rao HL, Chen JW, Li M et al (2012) Increased intratumoral neutrophil in colorectal carcinomas correlates closely with malignant phenotype and predicts patients’ adverse prognosis. PLoS ONE 7(1):e30806
Reichert TE, Scheuer C, Day R, Wagner W, Whiteside TL (2001) The number of intratumoral dendritic cells and zeta-chain expression in T cells as prognostic and survival biomarkers in patients with oral carcinoma. Cancer 91(11):2136–2147
Reid MD, Basturk O, Thirabanjasak D et al (2011) Tumor-infiltrating neutrophils in pancreatic neoplasia. Mod Pathol 24(12):1612–1619
Restifo NP, Kawakami Y, Marincola F et al (1993) Molecular mechanisms used by tumors to escape immune recognition: immunogenetherapy and the cell biology of major histocompatibility complex class I. J Immunother Emphasis Tumor Immunol 14(3):182–190
Ribatti D, Vacca A, Ria R et al (2003a) Neovascularisation, expression of fibroblast growth factor-2, and mast cells with tryptase activity increase simultaneously with pathological progression in human malignant melanoma. Eur J Cancer 39(5):666–674
Ribatti D, Ennas MG, Vacca A et al (2003b) Tumor vascularity and tryptase-positive mast cells correlate with a poor prognosis in melanoma. Eur J Clin Invest 33(5):420–425
Ribatti D, Finato N, Crivellato E et al (2005) Neovascularization and mast cells with tryptase activity increase simultaneously with pathologic progression in human endometrial cancer. Am J Obstet Gynecol 193(6):1961–1965
Rice AJ, Griffiths AP, Martin IG, Dixon MF (2000) Gastric carcinoma with prominent neutrophil infiltration. Histopathology 37(3):289–290
Rodriguez-Pinto D (2005) B cells as antigen presenting cells. Cell Immunol 238(2):67–75
Roncucci L, Mora E, Mariani F et al (2008) Myeloperoxidase-positive cell infiltration in colorectal carcinogenesis as indicator of colorectal cancer risk. Cancer Epidemiol Biomarkers Prev 17(9):2291–2297
Ropponen KM, Eskelinen MJ, Lipponen PK, Alhava E, Kosma VM (1997) Prognostic value of tumour-infiltrating lymphocytes (TILs) in colorectal cancer. J Pathol 182(3):318–324
Ryder M, Ghossein RA, Ricarte-Filho JC, Knauf JA, Fagin JA (2008) Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer. Endocr Relat Cancer 15(4):1069–1074
Sakaguchi S, Sakaguchi N, Shimizu J et al (2001) Immunologic tolerance maintained by CD25+ CD4+ regulatory T cells: their common role in controlling autoimmunity, tumor immunity, and transplantation tolerance. Immunol Rev 182:18–32
Salama P, Phillips M, Grieu F et al (2009) Tumor-infiltrating FOXP3+ T regulatory cells show strong prognostic significance in colorectal cancer. J Clin Oncol 27(2):186–192
Samoszuk M, Corwin MA (2003) Acceleration of tumor growth and peri-tumoral blood clotting by imatinib mesylate (Gleevec). Int J Cancer 106(5):647–652
Samoszuk M, Kanakubo E, Chan JK (2005) Degranulating mast cells in fibrotic regions of human tumors and evidence that mast cell heparin interferes with the growth of tumor cells through a mechanism involving fibroblasts. BMC cancer 5:121
Sato M, Yoshida H, Yanagawa T et al (1981) Carcinoma of the maxillary sinus with eosinophilia. Report of a case. Int J Oral Sur0067 10(1):62–67
Sato E, Olson SH, Ahn J et al (2005) Intraepithelial CD8+ tumor-infiltrating lymphocytes and a high CD8+/regulatory T cell ratio are associated with favorable prognosis in ovarian cancer. Proc Natl Acad Sci USA 102(51):18538–18543
Sawatsubashi M, Yamada T, Fukushima N, Mizokami H, Tokunaga O, Shin T (2000) Association of vascular endothelial growth factor and mast cells with angiogenesis in laryngeal squamous cell carcinoma. Virchows Arch 436(3):243–248
Schaerli P, Willimann K, Ebert LM, Walz A, Moser B (2005) Cutaneous CXCL14 targets blood precursors to epidermal niches for Langerhans cell differentiation. Immunity 23(3):331–342
Schleypen JS, Von Geldern M, Weiss EH et al (2003) Renal cell carcinoma-infiltrating natural killer cells express differential repertoires of activating and inhibitory receptors and are inhibited by specific HLA class I allotypes. Int J Cancer 106(6):905–912
Schleypen JS, Baur N, Kammerer R et al (2006) Cytotoxic markers and frequency predict functional capacity of natural killer cells infiltrating renal cell carcinoma. Clin Cancer Res 12(3 Pt 1):718–725
Schumacher K, Haensch W, Roefzaad C, Schlag PM (2001) Prognostic significance of activated CD8(+) T cell infiltrations within esophageal carcinomas. Cancer Res 61(10):3932–3936
Schwaab T, Schned AR, Heaney JA et al (1999) In vivo description of dendritic cells in human renal cell carcinoma. J Urol 162(2):567–573
Sharma MD, Baban B, Chandler P et al (2007a) Plasmacytoid dendritic cells from mouse tumor-draining lymph nodes directly activate mature Tregs via indoleamine 2, 3-dioxygenase. J Clin Investig 117(9):2570–2582
Sharma P, Shen Y, Wen S et al (2007b) CD8 tumor-infiltrating lymphocytes are predictive of survival in muscle-invasive urothelial carcinoma. Proc Natl Acad Sci USA 104(10):3967–3972
Sharma B, Sriram G, Saraswathi TR, Sivapathasundharam B (2010) Immunohistochemical evaluation of mast cells and angiogenesis in oral squamous cell carcinoma. Indian J Dent Res 21(2):260–265
Shellenberger TD, Wang M, Gujrati M et al (2004) BRAK/CXCL14 is a potent inhibitor of angiogenesis and a chemotactic factor for immature dendritic cells. Cancer Res 64(22):8262–8270
Shen Z, Zhou S, Wang Y et al (2010) Higher intratumoral infiltrated Foxp3+ Treg numbers and Foxp3+/CD8+ ratio are associated with adverse prognosis in resectable gastric cancer. J Cancer Res Clin Oncol 136(10):1585–1595
Shimizu K, Nakata M, Hirami Y, Yukawa T, Maeda A, Tanemoto K (2010) Tumor-infiltrating Foxp3+ regulatory T cells are correlated with cyclooxygenase-2 expression and are associated with recurrence in resected non-small cell lung cancer. J Thorac Oncol 5(5):585–590
Shojaei F, Zhong C, Wu X, Yu L, Ferrara N (2008) Role of myeloid cells in tumor angiogenesis and growth. Trends Cell Biol 18(8):372–378
Shurin GV, Ferris RL, Tourkova IL et al (2005) Loss of new chemokine CXCL14 in tumor tissue is associated with low infiltration by dendritic cells (DC), while restoration of human CXCL14 expression in tumor cells causes attraction of DC both in vitro and in vivo. J Immunol 174(9):5490–5498
Shurin MR, Shurin GV, Lokshin A et al (2006) Intratumoral cytokines/chemokines/growth factors and tumor infiltrating dendritic cells: friends or enemies? Cancer Metastasis Rev 25(3):333–356
Sica A, Bronte V (2007) Altered macrophage differentiation and immune dysfunction in tumor development. J Clin Investig 117(5):1155–1166
Sickert D, Aust DE, Langer S, Haupt I, Baretton GB, Dieter P (2005) Characterization of macrophage subpopulations in colon cancer using tissue microarrays. Histopathology 46(5):515–521
Simon HU, Haj-Yehia A, Levi-Schaffer F (2000) Role of reactive oxygen species (ROS) in apoptosis induction. Apoptosis 5(5):415–418
Simonetti O, Goteri G, Lucarini G et al (2007) In melanoma changes of immature and mature dendritic cell expression correlate with tumor thickness: an immunohistochemical study. Int J Immunopathol Pharmacol 20(2):325–333
Solinas G, Germano G, Mantovani A, Allavena P (2009) Tumor-associated macrophages (TAM) as major players of the cancer-related inflammation. J Leukoc Biol 86(5):1065–1073
Sorbye SW, Kilvaer T, Valkov A et al (2011) Prognostic impact of lymphocytes in soft tissue sarcomas. PLoS ONE 6(1):e14611
Sorbye SW, Kilvaer TK, Valkov A et al (2012a) Prognostic impact of peritumoral lymphocyte infiltration in soft tissue sarcomas. BMC Clin Pathol 12:5
Sorbye SW, Kilvaer T, Valkov A et al (2012b) High expression of CD20+ lymphocytes in soft tissue sarcomas is a positive prognostic indicator. Oncoimmunology 1(1):75–77
Sorbye SW, Kilvaer TK, Valkov A et al (2012c) Prognostic impact of CD57, CD68, M-CSF, CSF-1R, Ki67 and TGF-beta in soft tissue sarcomas. BMC Clin Pathol 12:7
Soucek L, Lawlor ER, Soto D, Shchors K, Swigart LB, Evan GI (2007) Mast cells are required for angiogenesis and macroscopic expansion of Myc-induced pancreatic islet tumors. Nat Med 13(10):1211–1218
Sozzani S, Luini W, Borsatti A et al (1997) Receptor expression and responsiveness of human dendritic cells to a defined set of CC and CXC chemokines. J Immunol 159(4):1993–2000
Sparmann A, Bar-Sagi D (2004) Ras-induced interleukin-8 expression plays a critical role in tumor growth and angiogenesis. Cancer Cell 6(5):447–458
Suto H, Nakae S, Kakurai M, Sedgwick JD, Tsai M, Galli SJ (2006) Mast cell-associated TNF promotes dendritic cell migration. J Immunol 176(7):4102–4112
Suzuki A, Masuda A, Nagata H et al (2002) Mature dendritic cells make clusters with T cells in the invasive margin of colorectal carcinoma. J Pathol 196(1):37–43
Takagi S, Miyagawa S, Ichikawa E et al (2004) Dendritic cells, T-cell infiltration, and Grp94 expression in cholangiocellular carcinoma. Hum Pathol 35(7):881–886
Takahashi A, Kono K, Itakura J et al (2002) Correlation of vascular endothelial growth factor-C expression with tumor-infiltrating dendritic cells in gastric cancer. Oncology 62(2):121–127
Takanami I, Takeuchi K, Naruke M (2000) Mast cell density is associated with angiogenesis and poor prognosis in pulmonary adenocarcinoma. Cancer 88(12):2686–2692
Takanami I, Takeuchi K, Giga M (2001) The prognostic value of natural killer cell infiltration in resected pulmonary adenocarcinoma. J Thoracic Cardiovasc Surg 121(6):1058–1063
Talmadge JE, Donkor M, Scholar E (2007) Inflammatory cell infiltration of tumors: Jekyll or Hyde. Cancer Metastasis Rev 26(3–4):373–400
Tan SY, Fan Y, Luo HS, Shen ZX, Guo Y, Zhao LJ (2005) Prognostic significance of cell infiltrations of immunosurveillance in colorectal cancer. World J Gastroenterol 11(8):1210–1214
Tataroglu C, Kargi A, Ozkal S, Esrefoglu N, Akkoclu A (2004) Association of macrophages, mast cells and eosinophil leukocytes with angiogenesis and tumor stage in non-small cell lung carcinomas (NSCLC). Lung cancer (Amsterdam, Netherlands) 43(1):47–54
Taylor CH, Shi SR, Barr NJ, Wu N (2006) Techniques of immunohistochemistry: principles, pitfalls and standardization. In: DD J (ed) Diagnostic immunohistochemistry. Churchill Livingstone Elsevier, Philadelphia
Tazawa H, Okada F, Kobayashi T et al (2003) Infiltration of neutrophils is required for acquisition of metastatic phenotype of benign murine fibrosarcoma cells: implication of inflammation-associated carcinogenesis and tumor progression. Am J Pathol 163(6):2221–2232
Tazzyman S, Lewis CE, Murdoch C (2009) Neutrophils: key mediators of tumour angiogenesis. Int J Exp Pathol 90(3):222–231
Theoharides TC, Conti P (2004) Mast cells: the Jekyll and Hyde of tumor growth. Trends Immunol 25(5):235–241
Thiel A, Pries R, Jeske S, Trenkle T, Wollenberg B (2009) Effect of head and neck cancer supernatant and CpG-oligonucleotides on migration and IFN-alpha production of plasmacytoid dendritic cells. Anticancer Res 29(8):3019–3025
Thompson AC, Bradley PJ, Griffin NR (1994) Tumor-associated tissue eosinophilia and long-term prognosis for carcinoma of the larynx. Am J Surg 168(5):469–471
Tomsova M, Melichar B, Sedlakova I, Steiner I (2008) Prognostic significance of CD3+ tumor-infiltrating lymphocytes in ovarian carcinoma. Gynecol Oncol 108(2):415–420
Toomey D, Smyth G, Condron C et al (2003) Infiltrating immune cells, but not tumour cells, express FasL in non-small cell lung cancer: No association with prognosis identified in 3-year follow-up. Int J Cancer 103(3):408–412
Toth T, Toth-Jakatics R, Jimi S, Takebayashi S (2000) Increased density of interstitial mast cells in amyloid A renal amyloidosis. Mod Pathol 13(9):1020–1028
Toth-Jakatics R, Jimi S, Takebayashi S, Kawamoto N (2000) Cutaneous malignant melanoma: correlation between neovascularization and peritumor accumulation of mast cells overexpressing vascular endothelial growth factor. Hum Pathol 31(8):955–960
Toy EP, Chambers JT, Kacinski BM, Flick MB, Chambers SK (2001) The activated macrophage colony-stimulating factor (CSF-1) receptor as a predictor of poor outcome in advanced epithelial ovarian carcinoma. Gynecol Oncol 80(2):194–200
Treilleux I, Blay JY, Bendriss-Vermare N et al (2004) Dendritic cell infiltration and prognosis of early stage breast cancer. Clin Cancer Res 10(22):7466–7474
Troy A, Davidson P, Atkinson C, Hart D (1998a) Phenotypic characterisation of the dendritic cell infiltrate in prostate cancer. J Urol 160(1):214–219
Troy AJ, Summers KL, Davidson PJ, Atkinson CH, Hart DN (1998b) Minimal recruitment and activation of dendritic cells within renal cell carcinoma. Clin Cancer Res 4(3):585–593
Troy AJ, Davidson PJ, Atkinson CH, Hart DN (1999) CD1a dendritic cells predominate in transitional cell carcinoma of bladder and kidney but are minimally activated. J Urol 161(6):1962–1967
Tsukayama S, Omura K, Yoshida K, Tanaka Y, Watanabe G (2005) Prognostic value of CD83-positive mature dendritic cells and their relation to vascular endothelial growth factor in advanced human gastric cancer. Oncol Rep 14(2):369–375
Tuna B, Yorukoglu K, Unlu M, Mungan MU, Kirkali Z (2006) Association of mast cells with microvessel density in renal cell carcinomas. Eur Urol 50(3):530–534
Vakkila J, Jaffe R, Michelow M, Lotze MT (2006) Pediatric cancers are infiltrated predominantly by macrophages and contain a paucity of dendritic cells: a major nosologic difference with adult tumors. Clin Cancer Res 12(7 Pt 1):2049–2054
van Driel WJ, Hogendoorn PC, Jansen FW, Zwinderman AH, Trimbos JB, Fleuren GJ (1996) Tumor-associated eosinophilic infiltrate of cervical cancer is indicative for a less effective immune response. Hum Pathol 27(9):904–911
Vermi W, Bonecchi R, Facchetti F et al (2003) Recruitment of immature plasmacytoid dendritic cells (plasmacytoid monocytes) and myeloid dendritic cells in primary cutaneous melanomas. J Pathol 200(2):255–268
Vermi W, Soncini M, Melocchi L, Sozzani S, Facchetti F (2011) Plasmacytoid dendritic cells and cancer. J Leukoc Biol 90(4):681–690
Vicari AP, Treilleux I, Lebecque S (2004) Regulation of the trafficking of tumour-infiltrating dendritic cells by chemokines. Semin Cancer Biol 14(3):161–169
Villegas FR, Coca S, Villarrubia VG et al (2002) Prognostic significance of tumor infiltrating natural killer cells subset CD57 in patients with squamous cell lung cancer. Lung cancer (Amsterdam, Netherlands) 35(1): 23–28
Vinten-Johansen J, Zhao ZQ, Nakamura M et al (1999) Nitric oxide and the vascular endothelium in myocardial ischemia-reperfusion injury. Ann N Y Acad Sci 874:354–370
Vivier E, Anfossi N (2004) Inhibitory NK-cell receptors on T cells: witness of the past, actors of the future. Nat Rev Immunol 4(3):190–198
Vora M, Romero LI, Karasek MA (1996) Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells. J Exp Med 184(3):821–829
Wakabayashi O, Yamazaki K, Oizumi S et al (2003) CD4+ T cells in cancer stroma, not CD8+ T cells in cancer cell nests, are associated with favorable prognosis in human non-small cell lung cancers. Cancer Sci 94(11):1003–1009
Walz A, Schmutz P, Mueller C, Schnyder-Candrian S (1997) Regulation and function of the CXC chemokine ENA-78 in monocytes and its role in disease. J Leukoc Biol 62(5):604–611
Walzer T, Jaeger S, Chaix J, Vivier E (2007) Natural killer cells: from CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol 19(3):365–372
Watkins SK, Zhu Z, Riboldi E et al (2011) FOXO3 programs tumor-associated DCs to become tolerogenic in human and murine prostate cancer. J Clin Investig 121(4):1361–1372
Welsh TJ, Green RH, Richardson D, Waller DA, O’Byrne KJ, Bradding P (2005) Macrophage and mast-cell invasion of tumor cell islets confers a marked survival advantage in non-small-cell lung cancer. J Clin Oncol 23(35):8959–8967
Westlin WF, Gimbrone MA Jr (1993) Neutrophil-mediated damage to human vascular endothelium. Role of cytokine activation. Am J Pathol 142(1):117–128
Westphal E (1891) Ferbenanlytische Untersuchungen Zur Histologie Und Klinik Des Blutes. In: Ehrlich P (ed) Uber mastzellen. Hirschwald, Berlin, p 17
Wilke CM, Kryczek I, Zou W (2011) Antigen-presenting cell (APC) subsets in ovarian cancer. Int Rev Immunol 30(2–3):120–126
Wislez M, Rabbe N, Marchal J et al (2003) Hepatocyte growth factor production by neutrophils infiltrating bronchioloalveolar subtype pulmonary adenocarcinoma: role in tumor progression and death. Cancer Res 63(6):1405–1412
Wolf D, Wolf AM, Rumpold H et al (2005) The expression of the regulatory T cell-specific forkhead box transcription factor FoxP3 is associated with poor prognosis in ovarian cancer. Clin Cancer Res 11(23):8326–8331
Woo EY, Yeh H, Chu CS et al (2002) Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J Immunol 168(9):4272–4276
Yanaba K, Bouaziz JD, Matsushita T, Magro CM (2008) St Clair EW, Tedder TF. B-lymphocyte contributions to human autoimmune disease. Immunol Rev 223:284–299
Yano H, Kinuta M, Tateishi H et al (1999) Mast cell infiltration around gastric cancer cells correlates with tumor angiogenesis and metastasis. Gastric Cancer 2(1):26–32
Yasuda M, Mizukami M, Hanagiri T et al (2006) Antigens recognized by IgG derived from tumor-infiltrating B lymphocytes in human lung cancer. Anticancer Res 26(5A):3607–3611
Yin XY, Lu MD, Lai YR, Liang LJ, Huang JF (2003) Prognostic significances of tumor-infiltrating S-100 positive dendritic cells and lymphocytes in patients with hepatocellular carcinoma. Hepatogastroenterology 50(53):1281–1284
Yu P, Fu YX (2006) lymphocytes: friends or foes? Laboratory Invest; J Tech Methods Pathol 86(3):231–245
Zeid NA, Muller HK (1993) S100 positive dendritic cells in human lung tumors associated with cell differentiation and enhanced survival. Pathology 25(4):338–343
Zhang W, Stoica G, Tasca SI, Kelly KA, Meininger CJ (2000) Modulation of tumor angiogenesis by stem cell factor. Cancer Res 60(23):6757–6762
Zhao JJ, Pan K, Wang W et al (2012) The prognostic value of tumor-infiltrating neutrophils in gastric adenocarcinoma after resection. PLOS ONE 7(3):e33655
Zhuang X, Xia X, Wang C et al (2010) A high number of CD8+ T cells infiltrated in NSCLC tissues is associated with a favorable prognosis. Appl Immunohistochem Mol Morphol 18(1):24–28
Zou W, Machelon V, Coulomb-L’Hermin A et al (2001) Stromal-derived factor-1 in human tumors recruits and alters the function of plasmacytoid precursor dendritic cells. Nat Med 7(12):1339–1346
Zudaire E, Martinez A, Garayoa M et al (2006) Adrenomedullin is a cross-talk molecule that regulates tumor and mast cell function during human carcinogenesis. Am J Pathol 168(1):280–291
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2013 Springer Science+Business Media Dordrecht
About this chapter
Cite this chapter
Gutkin, D.W. (2013). Tumor Infiltration by Immune Cells: Pathologic Evaluation and a Clinical Significance. In: Shurin, M., Umansky, V., Malyguine, A. (eds) The Tumor Immunoenvironment. Springer, Dordrecht. https://doi.org/10.1007/978-94-007-6217-6_3
Download citation
DOI: https://doi.org/10.1007/978-94-007-6217-6_3
Published:
Publisher Name: Springer, Dordrecht
Print ISBN: 978-94-007-6216-9
Online ISBN: 978-94-007-6217-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)